Thalidomide News and Research

RSS
Thalidomide is a drug that is used to treat multiple myeloma in patients who have just been diagnosed, and a painful skin disease related to leprosy. It is also being studied in the treatment of other types of cancer. Thalidomide belongs to the family of drugs called angiogenesis inhibitors. Also called Thalomid.
Drugmakers blamed for blocking generics have milked prices and cost U.S. billions

Drugmakers blamed for blocking generics have milked prices and cost U.S. billions

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

Legacy of social and political factors may be responsible for vaccine hesitancy

Legacy of social and political factors may be responsible for vaccine hesitancy

Desymmetrization paves way for new bioactive compounds

Desymmetrization paves way for new bioactive compounds

Valproic acid exposure results in characteristics linked to autism, zebrafish study shows

Valproic acid exposure results in characteristics linked to autism, zebrafish study shows

New tool developed to assess likely risk of drug turning into potentially harmful version

New tool developed to assess likely risk of drug turning into potentially harmful version

New study uncovers 13 previously-unknown genetic risk variants for restless legs syndrome

New study uncovers 13 previously-unknown genetic risk variants for restless legs syndrome

Childhood obesity starts in the womb?

Childhood obesity starts in the womb?

Additions to standard therapy do not improve progression-free survival in patients with multiple myeloma

Additions to standard therapy do not improve progression-free survival in patients with multiple myeloma

Chemists find efficient way to convert organic molecules into new medicines

Chemists find efficient way to convert organic molecules into new medicines

Mutations in STN1 gene cause Coats plus syndrome

Mutations in STN1 gene cause Coats plus syndrome

TUM researchers uncover molecular mechanism of thalidomide

TUM researchers uncover molecular mechanism of thalidomide

Leukemia & Lymphoma Society applauds FDA's recent approval of two new multiple myeloma drugs

Leukemia & Lymphoma Society applauds FDA's recent approval of two new multiple myeloma drugs

Innovative detector could expand use of polarized light for drug screening, surveillance

Innovative detector could expand use of polarized light for drug screening, surveillance

Continuous therapy improves multiple myeloma outcomes

Continuous therapy improves multiple myeloma outcomes

Steroid-refractory chronic GVHD trial results ‘overestimate’ treatment efficacy

Steroid-refractory chronic GVHD trial results ‘overestimate’ treatment efficacy

New method could help identify 'handedness' of different molecules in mixture

New method could help identify 'handedness' of different molecules in mixture

Maintenance therapy with lenalidomide benefits patients with multiple myeloma

Maintenance therapy with lenalidomide benefits patients with multiple myeloma

Combination of contraceptive and cholesterol-lowering drugs kills cancer cells in a new way

Combination of contraceptive and cholesterol-lowering drugs kills cancer cells in a new way

New treatment combinations improve outcomes for vulnerable patient with hard-to-treat disease

New treatment combinations improve outcomes for vulnerable patient with hard-to-treat disease